Last Updated: May 10, 2026

CLINICAL TRIALS PROFILE FOR PASIREOTIDE DIASPARTATE

✉ Email this page to a colleague

All Clinical Trials for pasireotide diaspartate

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05928390 ↗	Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia	ACTIVE_NOT_RECRUITING	RECORDATI GROUP	PHASE2	2024-01-04	The Total duration of trial participation for each participant with post-bariatric hypoglycemia will be a maximum of 59 weeks, with the following duration of trial periods * 19 weeks for the Core Phase. It is composed of: * a Screening period: a maximum of 3 weeks * a Run-in period (no treatment): 4 weeks * a Blinded Treatment Phase: 12 weeks * 36 weeks Extension Phase = an open-label Treatment period * 4 weeks for the safety follow-up period (without any treatment).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for pasireotide diaspartate

Condition Name

Chart
Table

Condition Name for pasireotide diaspartate
Intervention	Trials
Post-Bariatric Hypoglycemia	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for pasireotide diaspartate
Intervention	Trials
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for pasireotide diaspartate

Trials by Country

Map
Table

Trials by Country for pasireotide diaspartate
Location	Trials
United States	10
France	1
United Kingdom	1
Belgium	1
Spain	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for pasireotide diaspartate
Location	Trials
Wisconsin	1
Texas	1
Tennessee	1
New York	1
Minnesota	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for pasireotide diaspartate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for pasireotide diaspartate
Clinical Trial Phase	Trials
PHASE2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for pasireotide diaspartate
Clinical Trial Phase	Trials
ACTIVE_NOT_RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for pasireotide diaspartate

Sponsor Name

Chart
Table

Sponsor Name for pasireotide diaspartate
Sponsor	Trials
RECORDATI GROUP	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for pasireotide diaspartate
Sponsor	Trials
INDUSTRY	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.